Bovie Medical Corporation  

(Public, NYSEMKT:BVX)   Watch this stock  
Find more results for Ian J. McCarthy
+0.08 (2.51%)
Real-time:   11:06AM EST
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 3.46 - 3.46
52 week 3.00 - 5.00
Open 3.46
Vol / Avg. 332.00/16,981.00
Mkt cap 62.21M
P/E     -
Div/yield     -
EPS -1.01
Shares 18.01M
Beta 0.32
Inst. own 19%
May 13, 2015
Q1 2015 Bovie Medical Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Feb 27, 2015
Q4 2014 Bovie Medical Corp Earnings Call
Feb 27, 2015
Q4 2014 Bovie Medical Corp Earnings Release
Dec 3, 2014
Bovie Medical Corp at LD Micro Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -40.28% -18.34%
Operating margin -34.87% -15.49%
EBITD margin - -5.44%
Return on average assets -34.87% -14.14%
Return on average equity -145.14% -33.33%
Employees 136 -
CDP Score - -


United States - Map
+1-727-3842323 (Phone)
+1-631-4215821 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bovie Medical Corporation is a medical device company. The Company is engaged in manufacturing and marketing of electrosurgical devices. Its medical products include a range of devices, including electrosurgical generators and accessories, cauteries, medical lighting, nerve locators and other products. The Company sells a range of products designed for doctors�s offices, surgery centers and hospitals. The Company�s wholly owned subsidiaries include Aaron Medical Industries, Inc. and Bovie Canada ulc. Aaron Medical Industries, Inc. is principally engaged in the business of marketing the Company's medical products. Additionally, Bovie has original equipment manufacturing (OEM) agreements with other medical device manufacturers. The Company groups its products into three main categories: electrosurgery, cauteries and other products.

Officers and directors

Andrew Makrides Esq. Executive Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
J. Robert Saron President, Chief Sales and Marketing Officer, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert L. Gershon Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Peter L. Donato Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Age: 44
Bio & Compensation  - Reuters
Moshe Citronowicz Senior Vice President
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jack McCarthy Chief Commercialization Officer
Age: 47
Bio & Compensation  - Reuters
Shawn D. Roman Director - Research & Development
Bio & Compensation  - Reuters
Michael E. Geraghty Independent Director
Age: 66
Bio & Compensation  - Reuters
Ian D. Sheffield MBA Independent Director
Age: 37
Bio & Compensation  - Reuters
Lawrence J. Waldman CPA Independent Director
Age: 67
Bio & Compensation  - Reuters